SOPHiA GENETICS to Host Investor Day on September 20, 2022, in New York City
August 04, 2022 10:16 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Aug. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today it will host its...
SOPHiA GENETICS to Participate in Canaccord Genuity 42nd Annual Growth Conference
July 29, 2022 07:00 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, July 29, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Financial Officer, Ross Muken, will...
SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022
July 14, 2022 07:00 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the...
SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2022
May 10, 2022 07:00 ET
|
SOPHiA GENETICS, Inc.
BOSTON, United States and LAUSANNE, Switzerland, May 10, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today reported financial results for the first...
SOPHiA GENETICS to Attend and Host Investor Meetings at the J.P. Morgan 50th Annual Global Technology, Media, and Communications Conference
April 27, 2022 07:00 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, April 27, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced CFO, Ross Muken will attend the upcoming...
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2022 on May 10, 2022
April 13, 2022 07:00 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for...
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2021 Financial Results
March 15, 2022 07:02 ET
|
SOPHiA GENETICS, Inc.
Revenues Grew 40% for the Fourth Quarter and 42% for Full Year 20212022 Guidance Reaffirmed BOSTON and LAUSANNE, Switzerland, March 15, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a...
SOPHiA GENETICS to Participate in Fireside Chat at Barclays Global Healthcare Conference
March 04, 2022 08:00 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, March 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Executive Officer and Co-Founder Dr....
SOPHiA GENETICS to Announce Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022
February 16, 2022 07:00 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Feb. 16, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the...
SOPHiA GENETICS to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 29, 2021 07:00 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Dec. 29, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), announced today Chief Executive Officer and Co-Founder Dr. Jurgi Camblong and Chief Financial...